Company Cars vs Mileage Reimbursements in Pharmaceutical Sales

Pharmaceutical sales teams spend a lot of time on the road. Reps travel between healthcare providers, hospitals, clinics, pharmacies, and other accounts, which means transportation is not just an HR benefit. It is a real operating cost.

For years, pharmaceutical companies have relied heavily on company car fleets to keep sales representatives moving. And for some roles, fleet vehicles still make sense.

But they are not the only option.

When employees can do their jobs in standard passenger vehicles, companies can also reimburse them for using their personal vehicles for work. 

Mileage reimbursement programs can reduce the need to purchase or lease company cars while giving employers a structured way to cover business driving costs.

For pharmaceutical companies reviewing fleet costs, the question is not simply whether company cars are good or bad. It is whether every driver still needs one.

Why Pharmaceutical Companies Are Rethinking Company Car Fleets

A company car can be useful. The organization controls the vehicle, can establish a consistent standard across its field team, and does not require an employee to supply their own vehicle.

The tradeoff is cost and administration.

A company vehicle comes with expenses beyond the initial purchase or lease. Employers also need to account for depreciation, insurance, maintenance, registration, fuel, repairs, replacement cycles, and the internal resources required to manage those activities.

Fleet costs can be worthwhile when the vehicle itself is important to the job. A specialized or upfitted vehicle, for example, may be difficult to replace with an employee-owned car.

A pharmaceutical sales representative driving a standard passenger vehicle between customer meetings presents a different business case.

If the job requires transportation rather than a particular company-owned asset, reimbursing the employee for using a personal vehicle may offer a more practical alternative.

What Is A Mileage Reimbursement Program?

A mileage reimbursement program reimburses employees for the real, business-required cost of owning and operating a personal vehicle for work.

Instead of receiving a company car, pharmaceutical sales reps drive their own vehicles and receive reimbursement for business use.

Depending on the reimbursement method, that can account for vehicle expenses such as fuel, maintenance, insurance, registration, and depreciation.

Common approaches include Fixed and Variable Rate (FAVR), Cents-Per-Mile (CPM), and Tax-Free Car Allowances (TFCA).

The right choice depends on how much employees drive, where they work, and the needs of the organization.

Company Car Vs. Mileage Reimbursement: What's The Difference?

The biggest difference is who provides the vehicle.

With a company fleet, the employer purchases or leases vehicles and takes responsibility for managing those assets. 

With a mileage reimbursement program, employees provide their personal vehicles and the employer reimburses them for eligible business use.

That changes the economics of the program.

A fleet requires the company to carry vehicle costs even when utilization changes. A reimbursement program ties more of the company's spending to employees who are actually using personal vehicles for business.

It can also make scaling a field team easier. Hiring another sales rep does not necessarily mean sourcing, registering, and assigning another company car.

The better option depends on the role. Pharmaceutical companies do not have to choose one model for every employee.

What Does A Pharmaceutical Company Fleet Really Cost?

When comparing company cars with reimbursement, it helps to look beyond the monthly lease payment or vehicle purchase price.

Vehicle Acquisition And Depreciation

Vehicles lose value over time. For an organization operating hundreds or thousands of cars, depreciation becomes a significant part of the total cost of maintaining the program.

The company also needs a replacement strategy. Vehicles eventually have to be sold, returned, or replaced, creating an ongoing cycle of procurement and remarketing.

Fuel And Maintenance

High-mileage sales roles naturally generate fuel and maintenance costs.

Tires wear out. Oil needs to be changed. Vehicles need repairs. And fuel prices can fluctuate, as the IRS's midyear adjustment to the 2026 standard mileage rate illustrates.

The IRS increased the business standard mileage rate from 72.5 cents to 76 cents per mile beginning July 1, 2026, citing recent increases in fuel prices as the reason for the unusual midyear change.

For a large mobile workforce, even relatively small changes in vehicle operating costs can matter.

Insurance And Risk Management

Company-owned vehicles also create insurance and risk-management responsibilities.

That does not mean switching to personal vehicles eliminates employer risk. Employees driving their own cars for work still need appropriate insurance, and employers should establish clear vehicle and insurance requirements.

The difference is that a reimbursement model shifts vehicle ownership to the employee while giving the company an opportunity to establish and monitor standards for business driving.

Fleet Administration

There is also a less visible cost: time.

Someone has to manage vehicle orders, assignments, maintenance, registrations, fuel programs, insurance, replacements, and vehicles returned when employees leave or change roles.

For large pharmaceutical field teams, that administrative workload can become substantial.

Why Mileage Reimbursement Can Work Well For Pharmaceutical Sales Reps

Pharmaceutical sales is a natural use case for vehicle reimbursement because many representatives drive significant business mileage without requiring a specialized vehicle.

Large pharmaceutical sales teams can also be spread across territories throughout the country, with employees driving different amounts and facing different local vehicle costs. 

Transportation is essential to the job, but unlike a field service technician who may need an upfitted truck to carry tools or equipment, the vehicle itself often isn't the productive asset.

That makes pharmaceutical sales teams well suited to personal vehicle reimbursement. 

Instead of providing a company car simply because an employee needs to drive for work, organizations can reimburse employees for using their own vehicles and match different driver populations with FAVR, CPM, or TFCA based on their needs.

A structured reimbursement strategy can provide several advantages.

1. Costs Can Better Reflect Business Driving

Rather than providing an asset to every eligible employee, reimbursement focuses spending on the business use of employee-owned vehicles.

That can give Finance teams a clearer connection between driving activity and reimbursement spend.

2. Employees Have More Vehicle Choice

With a personal vehicle program, employees generally choose the vehicle they drive, subject to company policy and any applicable reimbursement-program requirements.

For a field sales representative who spends hours in their vehicle every week, that flexibility can be meaningful.

The company can still establish reasonable standards around insurance, vehicle condition, age, safety, or other business requirements.

3. Reimbursements Can Be Tax-Free When Properly Structured

A structured reimbursement program can also provide tax advantages when it is designed and administered properly.

Under IRS accountable plan rules, reimbursements that meet applicable requirements can generally be excluded from an employee's wages.

Those requirements include a business connection, adequate accounting or substantiation, and returning amounts paid in excess of substantiated expenses when required.

For pharmaceutical companies evaluating a move away from company cars, this means a personal vehicle program can reimburse employees for eligible business driving without treating qualifying reimbursements as taxable wages.

Is FAVR A Good Fit For Pharmaceutical Sales Teams?

Fixed and Variable Rate (FAVR) can be particularly useful for higher-mileage field employees.

FAVR reimburses drivers for the real, business-required cost of owning and operating a personal vehicle for work by separating vehicle expenses into two categories.

The fixed portion covers costs that do not change directly with every mile driven, such as insurance, registration, and depreciation. 

The variable portion addresses costs associated more directly with driving, such as fuel and maintenance.

This can be helpful for pharmaceutical sales teams because reps often operate across different geographic markets.

The cost of insurance, fuel, taxes, and other vehicle expenses can vary from one location to another. 

A well-designed FAVR program can account for those geographic differences rather than applying one national payment to every employee.

FAVR is governed by specific IRS requirements. For 2026, for example, the IRS set the maximum standard automobile cost used to calculate a FAVR allowance at $61,700.

Because of these requirements, FAVR needs to be designed and administered carefully. 

For geographically distributed pharmaceutical sales teams, that added structure can be valuable. FAVR can account for differences in local vehicle costs and business driving, rather than applying the same national rate to every employee.

What About Lower-Mileage Pharmaceutical Employees?

Not every employee needs FAVR.

Some managers, medical affairs employees, or other team members may drive for business only occasionally.

Cents-Per-Mile (CPM) can be a simpler fit for these employees. CPM reimburses drivers for the real, business-required cost of owning and operating their personal vehicle for work using a set reimbursement for each documented business mile.

Employers often use the IRS standard mileage rate as their CPM rate. From July 1 through December 31, 2026, that rate is 76 cents per business mile.

Another option is a Tax-Free Car Allowance (TFCA), which reimburses employees for the real, business-required cost of owning and operating a personal vehicle through an accountable allowance supported by substantiated business mileage.

This means a pharmaceutical company does not necessarily need to replace one uniform fleet policy with one uniform reimbursement policy.

Different driver populations can use different programs.

Do Pharmaceutical Companies Have To Replace Their Entire Fleet?

No.

In many cases, the more practical strategy is to determine which employees genuinely need company vehicles and which do not.

Roles that require specialized equipment, a specific vehicle configuration, or another operational requirement may remain in fleet.

High-mileage sales representatives using standard passenger vehicles could be evaluated for FAVR. Occasional drivers might use CPM. Other employee groups may fit TFCA.

This creates a mixed vehicle strategy where the program follows the needs of the role.

For a large pharmaceutical organization, that can also make a transition more manageable. The company can review driver populations, utilization, and costs instead of changing every vehicle assignment at once.

How To Transition Pharmaceutical Sales Reps From Company Cars To Reimbursement

Changing a vehicle program affects employees directly, so implementation matters just as much as the financial model.

Start with the data. Review which employees have company vehicles, how much business mileage they drive, what those vehicles cost, and whether their roles actually require a company-owned asset.

Then identify which reimbursement method fits each eligible driver population.

Employee communication should come early in the process. 

Sales reps will naturally want to know how their reimbursement is calculated, what vehicle requirements apply, what they need to document, and how the change affects them financially.

Mileage capture also needs to be simple. 

IRS-compliant reimbursement depends on appropriate substantiation, so employees need an easy way to maintain accurate business mileage records without creating a pile of administrative work every month.

Finally, review the program regularly. 

Territories, mileage, vehicle costs, and employee roles change. A program that made sense when it launched should not automatically remain unchanged for years.

A Better Pharmaceutical Vehicle Strategy Starts With The Role

Company cars are not inherently the wrong choice for pharmaceutical companies.

The problem comes when a company vehicle becomes the default for employees who do not actually need a company-owned asset to perform their jobs.

For pharmaceutical sales representatives driving standard passenger vehicles, a structured mileage reimbursement program can provide another option. 

It can reduce fleet management administration, connect vehicle spending more closely to business driving, give employees greater vehicle choice, and support tax-free reimbursement when the program meets applicable IRS requirements.

The strongest strategy may include more than one answer.

Some employees can remain in fleet. High-mileage sales reps may fit FAVR. Occasional drivers may be better suited to CPM, while other groups may fit TFCA.

At Cardata, we help companies design, implement, and manage vehicle reimbursement programs for employees who drive personal vehicles for work. 

Our software and managed services bring mileage capture, reimbursement calculations, compliance verification, payments, reporting, and driver support together in one program.

If you're reviewing your pharmaceutical fleet and wondering where reimbursement could fit, talk to a Cardata expert to learn more about your options.